Press and Media

How Lifespin revolutionizes the diagnosis of diseases with metabolic information and artificial intelligence

An interview by 5-HT Digital Hub Chemistry & Health with Dr. Ali Tinazli

Read More →

Lifespin Significantly Expands its Proprietary Database of Human Health Profiles in Oncology Under Newly Established Cooperative Scientific Agreement with the Medical University of Graz

lifespin’s agreement with Medical University Graz which garants access to more than 25,000 longitudinal blood samples

Read More →

The Bio Revolution Brings Innovation For Precision Diagnostics

Dr. Ali Tinazli’s first post at the Forbes magazine about “The Bio Revolution Brings Innovation For Precision Diagnostics”

Read More →

Metabolomics, an emerging clinical modality, enabling precision, personalized medicine

Metabolomics, an emerging clinical modality, enabling precision, personalized medicine

Read More →

Metabolomics: The Next Step in Precision Medicine

Metabolomics can measure the actual physiological state of an individual, providing new health insights

Read More →

Lifespin Establishes U.S. Corporate Entity in Anticipation of Market Expansion

BOSTON (MA), April 12th, 2022 — Lifespin GmbH, a deep data company that is mapping …

Read More →

Article about lifespin GmbH in the regional press (Donaukurier)

Das Regensburger Unternehmen Lifespin digitalisiert Stoffwechselproben und wagt heuer den Sprung in die USA – Auch die Harvard University ist bei der Entwicklung beteiligt

Read More →

lifespin GmbH secures €2.5M Bridge Financing

Lifespin GmbH Secures €2.5M Bridge Financing to Further Build its AI-Enabled
Metabolomics-Based Differential Diagnosis Panel for Neurological Diseases

Read More →

Article about lifespin GmbH in the clinical laboratory journal

Digitization of health

Read More →

In-depth feature of lifespin on GenomeWeb’s 360DX

Lifespin Using NMR to Develop Metabolomics-Based Diagnostics

Read More →
Scroll to Top